NexGel (NXGL) Stock: Buy, Sell, or Hold?
NXGL - NexGel, Inc Common Stock
$0.29
0.00 (0.34%)
▲
5d:
-14.23%
30d:
-29.16%
90d:
-50.66%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 18, 2026
0d
Get Alerted When NXGL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: NXGL is down 14.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: NXGL is down 14.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: NXGL is currently trading at $0.29, which is considered oversold relative to its 30-day fair value range of $0.32 to $0.43. From a valuation perspective, the stock is trading at a discount (Forward PE: -1.3) compared to its historical average (4.8). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, NXGL is in a strong downtrend. Immediate support is located at $0.27, while resistance sits at $0.38.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $2.00 (+587.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NXGL is in a strong downtrend. Immediate support is located at $0.27, while resistance sits at $0.38.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $2.00 (+587.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.32 -
$0.43
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
84.3%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 587.0% below Wall St target ($2.00)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- WARNING: Composite score 45/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.32 -
$0.43
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.27
Resistance Level
$0.38
Current Trend
Strong Downtrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.32
Wall Street Target
$2.00
(+587.0%)
Revenue Growth (YoY)
27.8%
Profit Margin
-51.3%
PE vs Historical
-1.3 vs 4.8
CHEAP
Share & Embed Analysis
Last updated: September 13, 2026 12:03 AM ET
Data refreshes hourly during market hours. Next update: 1:03 AM
Data refreshes hourly during market hours. Next update: 1:03 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NXGL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$478 | 53 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$85 | 35 SELL |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$405 | 63 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$188 | 45 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$246 | 41 HOLD |
